Michelle Doig is a Partner in Investments and Head of Corporate Development at Omega Funds. See sector focus and contact routes.
Michelle Doig is a Partner in Investments and Head of Corporate Development at Omega Funds, having joined the Boston-based venture capital firm in 2016 after over 20 years advising life sciences companies on financing and M&A. Her background includes prior roles as Director of Corporate Finance at Third Rock Ventures, Principal at Abingworth, and investment banker at Lehman Brothers, JP Morgan/H&Q, and Morgan Stanley. Omega Funds specializes in early-stage investments across life sciences, healthcare, and biotechnology, with a geographic focus on North America and Europe and therapeutic areas including oncology, immunology, rare diseases, and precision medicine. The firm invests across all growth stages, though specific check sizes and whether Doig typically leads or follows are not publicly detailed in available sources. One notable portfolio company where Doig serves as a board member is BridgeBio Oncology Therapeutics, reflecting the firm’s oncology focus. No distinctive public writing or unique point of view by Doig herself is documented in the search results, and further details on her typical check size or lead/follow behavior remain unverified.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Michelle Doig · Full investor directory · Investor access · Company funding database